WINDSOR JAMES BRIAN has filed 7 insider transactions across 1 company since November 2023.
Most recent transaction: a purchase of 239 shares of Rein Therapeutics, Inc. ($RNTX) on December 05, 2024.
Activity breakdown: 4 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 5, 2024 | Rein Therapeutics, Inc. | $RNTX | WINDSOR JAMES BRIAN | President and CEO | P | Common Stock | 239 | $2.24 | 7,586.0000 | 21,663,089 | 3.25% | 0.00% |
| Dec. 5, 2024 | Rein Therapeutics, Inc. | $RNTX | WINDSOR JAMES BRIAN | President and CEO | P | Common Stock | 161 | $2.25 | 7,508.0000 | 21,663,089 | 2.19% | 0.00% |
| Dec. 2, 2024 | Rein Therapeutics, Inc. | $RNTX | WINDSOR JAMES BRIAN | President and CEO | A | Stock Option (right to buy) | 517500 | $0.00 | 517,500.0000 | 21,663,089 | 9999.99% | 2.39% |
| March 5, 2024 | Rein Therapeutics, Inc. | $RNTX | WINDSOR JAMES BRIAN | President and COO | M | Common Stock | 2000 | $0.00 | 7,347.0000 | 4,598,715 | 37.40% | 0.04% |
| March 5, 2024 | Rein Therapeutics, Inc. | $RNTX | WINDSOR JAMES BRIAN | President and COO | M | Series X Non-Voting Convertible Preferred | 2 | $0.00 | 0.0000 | 4,598,715 | 100.00% | 0.00% |
| Dec. 15, 2023 | Rein Therapeutics, Inc. | $RNTX | WINDSOR JAMES BRIAN | President and COO | P | Common Stock | 225 | $3.37 | 5,347.0000 | 0 | 4.39% | 0.00% |
| Nov. 20, 2023 | Rein Therapeutics, Inc. | $RNTX | WINDSOR JAMES BRIAN | President and COO | P | Common Stock | 5076 | $1.97 | 5,122.0000 | 0 | 9999.99% | 0.00% |